Skip to main content
Clinical Trials/ACTRN12612001215819
ACTRN12612001215819
Active, not recruiting
Phase 3

Does a customised fetal growth chart compared to a non-customised fetal growth chart for use in routine antenatal care in singleton pregnancies reduce adverse perinatal outcome?

Mater Medical Research Institue0 sites3,993 target enrollmentNovember 16, 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Mater Medical Research Institue
Enrollment
3993
Status
Active, not recruiting
Last Updated
5 years ago